Results from the Kochi RYOMA Study. Atrial fibrillation is a major risk of morbidity in patients with hypertrophic cardiomyopathy.
Ohe
Tohru
T
D001281:Atrial Fibrillation / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000453:epidemiology* / Q000628:therapy; D018450:Disease Progression; D004617:Embolism / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D006333:Heart Failure / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D006801:Humans; D007564:Japan / Q000453:epidemiology; D015995:Prevalence; D012042:Registries; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors